Skip to main content

Advertisement

SpringerLink
Log in

Surgical adjuvant therapy for rectal cancer: Present options

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

Recent advances have been made with the publication of the results of GITSG and NCCTG trials, which demonstrated the significant improvement of survival by combined postoperative radiochemotherapy protocols for Stage II and III rectal cancer. These data show that systemic chemotherapy has a decisive role to play in this policy. Some of the advantages of preoperative irradiation compared with postoperative radiation therapy consist of the improvement of resectability of T4 tumors and the anal preservation for low-lying cancers. These data suggest that preoperative chemoradiotherapy should be applied not only to T4 tumors but also to all T3 tumors even when the transrectal extension is limited. The most usual protocol combines 5-fluorouracil (300–350 mg/m2/day) and leucovorin (20 mg/m2/day) for 5 days, followed by radiation therapy (30–35 Gy in 10 fractions within 12–15 days), with surgery taking place 4 to 8 weeks later, after the tumor has been restaged. Systemic therapy is continued for four more months. T2 cancers should not be excluded from the benefit of preoperative irradiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gastrointestinal Tumor Study Group. Survival afterpostoperative combination treatment of rectal cancer. N Engl J Med 1986;315:1294.

    Article  Google Scholar 

  2. Krook JE, Moertel CG, Gunderson LL,et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:710–66.

    Article  Google Scholar 

  3. NIH Consensus conference on adjuvant therapy for patients with colon and rectal cancers. JAMA 1990;264:1444–50.

    Google Scholar 

  4. Baslev JB, Pederson M, Teglebjaerg PS. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer 1986;58:22–8.

    PubMed  Google Scholar 

  5. Fisher B, Wolmark N, Rockette H,et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP Protocol R-01. J Natl Cancer Inst 1988;80:21.

    PubMed  CAS  Google Scholar 

  6. Gunderson LL. Intraoperative and external beam irradiation for locally advanced colorectal cancer. Ann Surg 1988;207:52–60.

    PubMed  CAS  Google Scholar 

  7. Allee PE, Tepper JE, Gunderson LL, Munzenrider JE. Postoperative radiotherapy for incompletely resected colorectal cancer. Int J Radiat Oncol Biol Phys 1989;17:1171–6.

    PubMed  CAS  Google Scholar 

  8. Stevens KR, Fletcher WS. High dose preoperative irradiation for unresectable adenocarcinoma of the rectum and sigmoid. Int J Radiat Oncol Biol Phys 1983;9:148.

    Google Scholar 

  9. Dosoretz DE, Gunderson LL, Hedbcrg S,et al. Preoperative irradiation of unresectable rectal and rectosigmoid carcinomas. Cancer 1983;52:814–8.

    PubMed  CAS  Google Scholar 

  10. Emami B, Pilepitch M, Willett C, Munzenrider JE, Miller HH. Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys 1982;8:1295–9.

    PubMed  CAS  Google Scholar 

  11. Mella O, Dahl O, Horn A, Morild IS, Odland G. Radiotherapy and resection for apparently inoperable rectal adenocarcinoma. Dis Colon Rectum 1983;27:663–8.

    Google Scholar 

  12. Tepper JE, Wood WC, Cohen AM. Treatment of locally advanced rectal cancer with external beam radiation, surgical resection and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1989;16:1437–44.

    PubMed  CAS  Google Scholar 

  13. Minsky BD, Cohen AM, Enker WE,et al. Phase I trial of postoperative FU, radiation therapy and high dose leucovorin for resectable rectal cancer. Int J Radiat Oncol Biol Phys 1991;22:139–45.

    Google Scholar 

  14. Pahlman L, Glimelius B. Preor post-operative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicenter trial. Ann Surg 1990;211:187.

    PubMed  CAS  Google Scholar 

  15. Gerard A, Buyse M, Nordlinger B,et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer: final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988;208:606.

    Article  PubMed  CAS  Google Scholar 

  16. Stockholm Rectal Cancer Group. Preoperative shortterm radiation therapy in operable rectal carcinoma. A prospect randomized trial. Cancer 1990;66:49–55.

    Google Scholar 

  17. Mendenhall WM, Bland KI, Rout WR, Pfaff WW, Million RR, Copeland EM. Clinically resectable adenocarcinoma of the rectum treated with preoperative irradiation and surgery. Dis Colon Rectum 1988;31:287.

    PubMed  CAS  Google Scholar 

  18. Berard P, Papillon J. Role of pre-operative irradiation for anal preservation in cancer of the low rectum. World J Surg 1992;16:502–9.

    PubMed  CAS  Google Scholar 

  19. Marks G, Mohiuddin M, Goldstein SD. Sphincter preservation for cancer of the distal rectum using high dose preoperative radiation. Int J Radiat Oncol Biol Phys 1988;15:1065.

    PubMed  CAS  Google Scholar 

  20. Friedman P, Garb JL, McCabe DP,et al. Intestinal anastomosis after preoperative radiation therapy for carcinoma of the rectum. Surg Gynecol Obstet 1987;164:257.

    PubMed  Google Scholar 

  21. Roberson SH, Heron HC, Herman HD, Bloom TS. Is anterior resection of the rectosigmoid safe after preoperative radiation? Dis Colon Rectum 1985;28:254.

    PubMed  CAS  Google Scholar 

  22. Marks G, Mohiuddin M, Eitan A, Masoni L, Rakinic J. High dose preoperative radiation and radical sphincter-saving surgery for rectal cancer. Arch Surg 1991;126:1534–40.

    PubMed  CAS  Google Scholar 

  23. Papillon J. The future of external beam irradiation as initial treatment of rectal cancer. Br J Surg 1987;74:449–54.

    PubMed  CAS  Google Scholar 

  24. Willett CG, Lewandrowski K, Donnelly S,et al. Are there patients with stage 1 rectal carcinoma at risk for failure after abdominoperineal resection? Cancer 1992;69;1651–5.

    PubMed  CAS  Google Scholar 

  25. Minsky BD, Cohen AM, Enker W,et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. ASCO Proc 1992;11:160.

    Google Scholar 

  26. Poon MA, O'Connell MJ, Wieand HS,et al. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 1991;9:1967–72.

    PubMed  CAS  Google Scholar 

  27. Dubois JB, Rouanet TP, Saint-Aubert B,et al. La radiothérapie préopératoire dans le cancer du rectum. 307 cas évaluables. Recul minimum 6 ans. Lyon Chir (France) 1991;87:9–13.

    Google Scholar 

  28. Minsky BD, Kemeny N, Cohen AM,et al. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 1991;67:2859–66.

    PubMed  CAS  Google Scholar 

  29. James R, Gray R. Options thérapeutiques dans le cancer du rectum. Expérience du Nord-Est de l'Angleterre et projet AXIS. Lyon Chir (France) 1991;87:17–20.

    Google Scholar 

  30. Minsky BD, Cohen AM, Kemeny N,et al. Enhancement of radiation induced downstaging of rectal cancer by fluorouracil and high dose leucovorin chemotherapy. J Clin Oncol 1992;10:79–84.

    PubMed  CAS  Google Scholar 

  31. O'Connell MJ, Gunderson LL. Adjuvant therapy for adenocarcinoma of the rectum. World J Surg 1992;16:510–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre Léon Bérard, Lyon, France

    J. Papillon M.D., H.F.R.C.R.

Authors
  1. J. Papillon M.D., H.F.R.C.R.
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Papillon, J. Surgical adjuvant therapy for rectal cancer: Present options. Dis Colon Rectum 37, 144–148 (1994). https://doi.org/10.1007/BF02047536

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02047536

Key words

Search

Navigation